About Quantum Technology Partners
Quantum Technology Partners is a venture capital firm founded in 2000. It is primarily based out of San Jose, United States. As of Apr 2013, Quantum Technology Partners has invested in 15 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Telecom and Semiconductors. Most recently it participated in the $***** Series A round of Anterios Overall, Quantum Technology Partners portfolio has seen 1 unicorn, 2 IPOs and 7 acquisitions including key companies like PAX Labs, Vaxart and Corium. A lot of funds co-invest with Quantum Technology Partners, with names like EW Healthcare Partners sharing a substantial percentage of its portfolio. Quantum Technology Partners has team of 1 people including 1 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 2 more
Portfolio Acquisitions
Portfolio Unicorns
Quantum Technology Partners' List of Top Investments
Quantum Technology Partners has a portfolio of 15 companies, one of which is a Unicorn. Their most notable investments are in Anterios and Vaxart.Their portfolio spans across United States, Israel, Switzerland and 1 more locations. They have invested in Life Sciences, Telecom, Semiconductors and 6 other sectors, across stages such as Series A, Series B and 2 more. Here is the list of top investments by Quantum Technology Partners:_1571634296084.png?format=webp&height=120&width=120){kind=logo}
1. PAX Labs
Internet-first brand offering cannabis-infused vapor products. It offers multi-category products like cannabis-infused vape, cannabis, and accessories for smoking product
Key facts about PAX Labs
- Founded Year: 2007
- Location: San Francisco (United States)
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $571M
- Employee Count: 427 as on Aug 31, 2026
- Investors: Oceanic Partners, Fidelity Investments and 28 Others
- Latest Funding Round: Series E, Apr 12, 2019, $*****
- Highlight: Editors' Pick
2. Vaxart
Developer of therapeutic solutions for treating multiple infectious diseases. The proprietary delivery platform of the company can deliver recombinant vaccines, thus enabling vaxart to introduce oral versions of certain vaccines. The pipeline includes vaccines for seasonal influenza, norovirus, RSV, HSV-2, avian influenza vaccine, and ebola vaccine. It has also developed vaccines for the treatment of influenza.
Key facts about Vaxart
- Founded Year: 2004
- Location: San Francisco (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $58M
- Employee Count: 110 as on Sep 30, 2026
- Investors: Care Capital, Codon Capital and 8 Others
- Latest Funding Round: Series C, Jan 08, 2015, $*****
- Highlight: Public
3. Corium
Developer of drugs for central nervous system disorders. The lead product AZSTARYS capsules contain serdexmethylphenidate and dexmethylphenidate is a CNS stimulant indicated for the treatment of attention deficit hyperactivity disorder. Also, has the drug candidate Corplex is a transdermal formulation of donepezil for the treatment of Alzheimer’s disease.
Key facts about Corium
- Founded Year: 1999
- Location: Grand Rapids (United States)
- Annual Revenue: $10M - $50M as on Sep 30, 2017
- Stage: Public
- Total Funding till date: $40M
- Employee Count: 247 as on Sep 30, 2026
- Investors: CRG, Portugal Ventures and 9 Others
- Latest Funding Round: Conventional Debt, Sep 27, 2021, $*****
- Highlight: Public
4. Anterios
Research-based biopharmaceutical company discovering and delivering innovative medicines, focused on researching, developing, manufacturing, and commercializing advanced therapies. The company is committed to addressing some of the world's most complex and serious diseases. It provides resources for news, media, investors, and patients. The organization operates with a focus on ethical practices, adhering to community guidelines on social media channels. It emphasizes the importance of accurate and up-to-date information, while acknowledging the historical context of its press releases. The company respects user privacy, providing options for cookie settings and data privacy choices. It holds trademarks for its product names and actively manages its online presence through various social media platforms.
Key facts about Anterios
- Founded Year: 2006
- Location: New York City (United States)
- Stage: Acquired
- Total Funding till date: $26.9M
- Employee Count: 8 as on Dec 31, 2014
- Investors: Colt Ventures, Ascent Biomedical Ventures and 5 Others
- Latest Funding Round: Series A, Apr 24, 2013, $*****
- Highlight: Acquired
Developer of PARP inhibitors for cancer therapies. The company's lead product is BSI-201 for advanced breast cancer, ovarian cancer, and other tumors.
Key facts about BiPar Sciences
- Founded Year: 2002
- Location: Brisbane (United States)
- Stage: Acquired
- Total Funding till date: $68M
- Investors: Domain Associates, Canaan and 8 Others
- Latest Funding Round: Series C, Jan 12, 2009, $*****
- Highlight: Acquired
Quantum Technology Partners' Investments by Stage
Quantum Technology Partners has made 4 investments in Series A stage with an average round size of $7.6M, 2 investments in Series B stage with an average round size of $17.5M, 2 investments in Series C stage with an average round size of $50M and 2 investments in Series D stage with an average round size of $28.5M.Stage of entry | No. of Investments |
|---|---|
Series A | 4 |
Series B | 2 |
Series C | 2 |
Series D | 2 |
Note: We have considered here, only first round of investments
Quantum Technology Partners' Investments by Sector
Quantum Technology Partners has a diverse portfolio, with companies operating in the Life Sciences, Telecom, Enterprise Applications, Enterprise Infrastructure and Industrial Goods and Manufacturing. Notably, it has invested in 13 Tech companies, 12 Enterprise (B2B) companies, 6 Software companies and at least 5 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 6 |
Telecom | 2 |
Enterprise Applications | 1 |
Enterprise Infrastructure | 1 |
Industrial Goods and Manufacturing | 1 |
Others | 2 |
Note: We have considered here, only first round of investments
Quantum Technology Partners' Investments by Geography
Quantum Technology Partners has made most investments in United States (9), followed by Switzerland where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 9 |
Switzerland | 1 |
Note: We have considered here, only first round of investments
Quantum Technology Partners' recent investments
Quantum Technology Partners has not made any investment in 2026 so far.Here are the most recent investments by Quantum Technology Partners:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Apr 24, 2013 | United States | Series A | 6231 | ||
Jun 29, 2012 | United States | Series B | 4233 | [+1] | |
Jan 12, 2009 | United States | Series C | 5708 | [+4] | |
Nov 15, 2007 | United States | Series A | 6925 | ||
Sep 26, 2007 | United States | Series C | 2674 |
Unicorns in Quantum Technology Partners' Portfolio
Quantum Technology Partners has 1 unicorn in its portfolio - PAX Labs. The most recent unicorn in their portfolio is PAX Labs which became a unicorn in 2019, 7 years before Quantum Technology Partners first invested in it.Here is a list of unicorns in Quantum Technology Partners' portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
73 | Internet-first brand offering cannabis-infused vapor products | 2007 | San Francisco | Series E | omtgjof |
IPOs and Publicly Listed companies in Quantum Technology Partners' Portfolio
2 of Quantum Technology Partners' portfolio companies have become public. Vaxart got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Feb 2018 and Corium got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $52M.Here are Quantum Technology Partners' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Feb 12, 2018 | Nov 15, 2007 | Series A | 4606 | |
Apr 03, 2014 | Sep 26, 2007 | Series C | 9066 |
Acquired companies in Quantum Technology Partners' Portfolio
7 companies from Quantum Technology Partners' portfolio have been acquired. The most recent acquisition was Anterios in Jan 2016 by Allergan for $*****.Here are Quantum Technology Partners' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 07, 2016 | Apr 24, 2013 | Series A | 4542 | |
Nov 15, 2013 | Oct 2006 | Series B | 3247 | |
Apr 15, 2009 | Dec 20, 2004 | Series A | 7274 | |
Sep 10, 2008 | - | - | 5783 | |
Sep 27, 2007 | May 10, 2007 | Series B | 5495 |
Team profile of Quantum Technology Partners
Quantum Technology Partners has a team of 1 member located in United States. Quantum Technology Partners' team does not sit on the board of any company as of now.Co-investors of Quantum Technology Partners
Over the past 26 years, 46 investors have co-invested in Quantum Technology Partners's portfolio companies. This includes only funds.
- Invested before Quantum Technology Partners: HHS, SCP Partners and 3 others have invested in rounds before Quantum Technology Partners. There is 1 company where HHS has invested before Quantum Technology Partners and 1 company where SCP Partners has invested before Quantum Technology Partners.
- Top Co-investors of Quantum Technology Partners: 29 investors entered a company along with Quantum Technology Partners. These include investors like EW Healthcare Partners (2 companies).
- Invested after Quantum Technology Partners: A total of 12 investors have invested in Quantum Technology Partners's portfolio after their investments. Top Investors include Care Capital (1 company), Care Capital Management (1 company) and Hercules Capital (1 company).
Recent News related to Quantum Technology Partners
•
Vaxart Raises $12.5M Series B Financing |FinSMEsFinSMEs•Mar 04, 2010•Vaxart, Care Capital, Quantum Technology Partners, Life Science Angels
•
Vaxart gets $3.5M injection to make vaccinations oral | VentureBeatVentureBeat•Jan 14, 2010•Vaxart, Care Capital, Quantum Technology Partners, Life Science Angels
•
Sanofi to acquire BiPar SciencesStrategic Transactions•Apr 01, 2009•BiPar Sciences, Sanofi, Sanofi, BiPar Sciences and 6 others
•
•
StrataGent closes $16M funding roundThe Business Journals•May 10, 2007•Stratagent Life Sciences, Quantum Technology Partners, Aphelion Capital, EW Healthcare Partners
•
CORRECTING and REPLACING Global Life Science Ventures and Abingworth invest in IMI Intelligent Medical Implants AG | Business WireBusiness Wire•Oct 30, 2006•Intelligent Medical Implants, Abingworth, Quantum Technology Partners, Global Life Science Ventures
•
•
Silverstar Holdings Affiliate, Magnolia Broadband Receives $14 Million in Series D Funding
Marketwired•Magnolia Broadband, Quantum Technology Partners, Silverstar Holdings
•
